Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by-nc (c) Carpio, Luis P. del et al., 2025
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/222780

Molecular determinants of survival in metastatic uveal melanoma: The impact of SF3B1 mutations

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Purpose: To determine whether key molecular alterations in primary uveal melanoma (UM), including mutations and somatic copy number alterations (SCNAs), serve as prognostic markers in metastatic UM (MUM). Experimental design: Retrospective analysis of a prospective cohort study of clinical and molecular data from UM and MUM patients. Results: A total of 220 patients with primary UM treated at Hospital de Bellvitge, including 79 (36 %) who developed metastases, primarily in the liver. Genetic analyses of primary tumors included hotspot mutation testing for GNAQ, GNA11, and SF3B1, along with SCNA assessment (chromosomes 3, 8, 1, and 6) via Multiplex Ligation-dependent Probe Amplification (MLPA). Kaplan-Meier and Cox proportional hazards models assessed the impact of genetic alterations on relapse-free survival (RFS) and overall survival (OS) . Results: Monosomy 3 (M3) and chromosome 8q amplification (8A) were associated with shorter RFS (p <0.0001) in primary UM but did not impact OS in MUM (p = 0.33). SF3B1 mutations (SF3B1m) conferred significantly longer OS in MUM (31.7 vs. 11.8 months, p = 0.001), independently confirmed in multivariate analysis (HR=0.26, p = 0.01), irrespective of tebentafusp treatment. Conclusions: Traditional chromosomal markers stratify primary UM but fail to predict OS in MUM. SF3B1m emerges as a novel prognostic factor, indicating a distinct biological phenotype with potential therapeutic implications. Further studies are warranted to validate its prognostic and therapeutic relevance in MUM.

Matèries

Matèries (anglès)

Citació

Citació

CARPIO, Luis p. del, VARELA RODRÍGUEZ, Mar, PORTU GRIVÉ, Mikel, VILLATORO, Sergi, PURQUERAS, Elvira, GOMÀ, Montse, LORENZO PARRA, Daniel, LLADÓ GARRIGA, Laura, GUTIERREZ, Cristina, RAMOS RUBIO, Emilio, CAMINAL MITJANA, Josep maria, PIULATS, Josep m.. Molecular determinants of survival in metastatic uveal melanoma: The impact of SF3B1 mutations. _European Journal of Cancer_. 2025. Vol. 226, núm. 115591. [consulta: 24 de gener de 2026]. ISSN: 0959-8049. [Disponible a: https://hdl.handle.net/2445/222780]

Exportar metadades

JSON - METS

Compartir registre